<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>Oral Cancer News</title>
	
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Wed, 08 Feb 2012 17:06:10 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/oralcancernews/KsIl" /><feedburner:info uri="oralcancernews/ksil" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>Cisplatin Aids Survival of High-Risk Head and Neck Cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/ntWvT6bJJaI/</link>
		<comments>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer-2/#comments</comments>
		<pubDate>Wed, 08 Feb 2012 17:06:10 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society for Radiation Therapy]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[head and neck carcinoma]]></category>
		<category><![CDATA[Radiation Therapy Oncology Group]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12444</guid>
		<description><![CDATA[Source: Oncology Report Adding chemotherapy to radiotherapy improved 10-year survival of resectable head and neck carcinomas among high-risk patients who had microscopically involved resection margins and/or extracapsular spread of disease – but not in high-risk patients who only had tumor in multiple lymph nodes. The findings come from a long-term update and unplanned subset analysis [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer-2/</feedburner:origLink></item>
		<item>
		<title>3D printer provides woman with a brand new jaw</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/1M601sRWuY4/</link>
		<comments>http://oralcancernews.org/wp/3d-printer-provides-woman-with-a-brand-new-jaw/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 22:09:34 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[dental implants]]></category>
		<category><![CDATA[MRI scans]]></category>
		<category><![CDATA[osteomyelitis]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12434</guid>
		<description><![CDATA[Source: New Scientist &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; An 83-year-old Belgian woman is able to chew, speak and breathe normally again after a machine printed her a new jawbone. Made from a fine titanium powder sculpted by a precision laser beam, her replacement jaw has proven as functional as her own [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/3d-printer-provides-woman-with-a-brand-new-jaw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/3d-printer-provides-woman-with-a-brand-new-jaw/</feedburner:origLink></item>
		<item>
		<title>PET/CT Detects Early Recurrence of Head and Neck Cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/JFroJHpRzhA/</link>
		<comments>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 18:43:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society for Radiation Oncology]]></category>
		<category><![CDATA[chemoradiation]]></category>
		<category><![CDATA[Multidisciplinary Head and Neck Cancer Symposium]]></category>
		<category><![CDATA[salvage therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12430</guid>
		<description><![CDATA[Source: Elsevier Global Medical News Routine use of positron emission tomography/computed tomography scans can detect locoregional recurrences of squamous cell carcinoma of the head and neck before they became clinically apparent, according to a retrospective chart review of 234 patients who had been treated with chemoradiation between 2006 and 2010.  The finding suggests that routine use [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/</feedburner:origLink></item>
		<item>
		<title>Head and neck cancer carries substantial comorbidity burden</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/BfmrZP5nt-c/</link>
		<comments>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 17:16:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[comorbidity]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12428</guid>
		<description><![CDATA[Source: MedWire News People with head and neck cancer experience a high burden of both acute and chronic comorbidity, shows an analysis of a large Dutch population-based cohort. The researchers therefore advise clinicians to account for patients&#8217; comorbidity burden when assessing the risk-benefit profile for different treatment options. Sarah Landis (GlaxoSmithKline, London, UK) and co-workers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/</feedburner:origLink></item>
		<item>
		<title>UT MD Anderson article offers one roadmap for defining value in health care, earns national award from leading journal</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/EvyaRDN-0Jc/</link>
		<comments>http://oralcancernews.org/wp/ut-md-anderson-article-offers-one-roadmap-for-defining-value-in-health-care-earns-national-award-from-leading-journal/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 02:56:16 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[costs]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[patient outcomes]]></category>
		<category><![CDATA[survival]]></category>
		<category><![CDATA[value proposition]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12422</guid>
		<description><![CDATA[Source: http://www.newswise.com Author: University of Texas M. D. Anderson Cancer Center A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising. The MD Anderson study took [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/ut-md-anderson-article-offers-one-roadmap-for-defining-value-in-health-care-earns-national-award-from-leading-journal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/ut-md-anderson-article-offers-one-roadmap-for-defining-value-in-health-care-earns-national-award-from-leading-journal/</feedburner:origLink></item>
		<item>
		<title>Tumeric and Curcumin offer powerful anti-cancer health benefits naturally</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/OeVLCRvgROM/</link>
		<comments>http://oralcancernews.org/wp/tumeric-and-curcumin-offer-powerful-anti-cancer-health-benefits-naturally/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 02:49:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[curcumin]]></category>
		<category><![CDATA[phenol]]></category>
		<category><![CDATA[toxicity]]></category>
		<category><![CDATA[tumeric]]></category>
		<category><![CDATA[tumor size]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12418</guid>
		<description><![CDATA[Source: www.sacbee.com Author: staff Commonly used in many Eastern countries, tumeric has been found to suppress cancer growth and reduce brain tumors by an astounding 81% without evidence of toxicity. While the benefits of turmeric are just coming to light within the mainstream and alternative media, it has been known for quite some time that [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/tumeric-and-curcumin-offer-powerful-anti-cancer-health-benefits-naturally/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/tumeric-and-curcumin-offer-powerful-anti-cancer-health-benefits-naturally/</feedburner:origLink></item>
		<item>
		<title>Cisplatin aids survival of high-risk head and neck cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/iVpV9eoefy4/</link>
		<comments>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 02:44:50 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[extracapsular spread]]></category>
		<category><![CDATA[margins]]></category>
		<category><![CDATA[nodes]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12412</guid>
		<description><![CDATA[Source: www.oncologyreport.com Author: Miriam E. Tucker Adding chemotherapy to radiotherapy improved 10-year survival of resectable head and neck carcinomas among high-risk patients who had microscopically involved resection margins and/or extracapsular spread of disease – but not in high-risk patients who only had tumor in multiple lymph nodes. The findings come from a long-term update and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/</feedburner:origLink></item>
		<item>
		<title>Cancer Patients’ Health Benefits From Physical Activity</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/8bIm_Jd1mQs/</link>
		<comments>http://oralcancernews.org/wp/cancer-patients-health-benefits-from-physical-activity/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 17:35:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[BMI]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[physical activity]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12408</guid>
		<description><![CDATA[Source: MedicalNewsToday.com According to an investigation published on bmj.com, cancer patients who have completed their primary cancer-related treatment, who engage in physical activity, can enhance their health. Earlier studies discovered that individuals with cancer anticipate to return to normal daily activities after completing their primary cancer-related treatment. However, these patients often find they experience lower [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cancer-patients-health-benefits-from-physical-activity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/cancer-patients-health-benefits-from-physical-activity/</feedburner:origLink></item>
		<item>
		<title>HPV Vaccine Not Linked To Autoimmune Disorders, Study</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/pYle1Caw7ps/</link>
		<comments>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 17:32:47 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[Journal of Internal Medicine]]></category>
		<category><![CDATA[Kaiser Permanente Department of Research & Evaluation]]></category>
		<category><![CDATA[Merck & Co.]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12406</guid>
		<description><![CDATA[Source: MedicalNewsToday.com A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck &#38; Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine. Study lead author Dr Chun [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/hpv-vaccine-not-linked-to-autoimmune-disorders-study/</feedburner:origLink></item>
		<item>
		<title>Connected nodes in throat cancer signal poor prognosis</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/-7UUKCQ5858/</link>
		<comments>http://oralcancernews.org/wp/connected-nodes-in-throat-cancer-signal-poor-prognosis/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 00:10:15 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[Head and Neck surgery]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinoma]]></category>
		<category><![CDATA[radiation therapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12403</guid>
		<description><![CDATA[Source: OncologyNurseAdvisor.com The presence of “matted” lymph nodes in persons with oropharyngeal squamous cell carcinoma (SCC)—that is, nodes that are connected together—was associated with a 3-year survival rate of 69%, compared with 94% among patients without matted nodes. Such a marker could help clinicians identify patients who are at heightened risk for metastasis and who [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/connected-nodes-in-throat-cancer-signal-poor-prognosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/connected-nodes-in-throat-cancer-signal-poor-prognosis/</feedburner:origLink></item>
		<item>
		<title>Queensland researchers make cancer treatment breakthrough</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/6gdnmE9f4Kk/</link>
		<comments>http://oralcancernews.org/wp/queensland-researchers-make-cancer-treatment-breakthrough/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 00:06:54 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Australian Centre for Vaccine Development]]></category>
		<category><![CDATA[cancer cells]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[immune system]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[nasopharyngeal carcinoma]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[throat cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12401</guid>
		<description><![CDATA[Source: HealthCanal.com The culmination of 10 years of collaborative research between scientists from the Queensland Institute of Medical Research (QIMR) and The University of Hong Kong (HKU) Li Ka Shing Faculty of Medicine has led to a significant breakthrough in the treatment of nasopharyngeal carcinoma (NPC), an aggressive throat cancer with a high prevalence in [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/queensland-researchers-make-cancer-treatment-breakthrough/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/queensland-researchers-make-cancer-treatment-breakthrough/</feedburner:origLink></item>
		<item>
		<title>The search for biomarkers of disease in spit</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/dNd0OBPZN6o/</link>
		<comments>http://oralcancernews.org/wp/the-search-for-biomarkers-of-disease-in-spit/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 23:38:53 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biomaker proteins]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral inflammation]]></category>
		<category><![CDATA[saliva]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12398</guid>
		<description><![CDATA[Source: University of Minnesota It&#8217;s a researcher&#8217;s dream: a simple, noninvasive test to detect life-threatening cancer, heart disease, or other maladies while they&#8217;re still treatable. A team of University of Minnesota researchers is in hot pursuit of that goal, using one of the simplest means imaginable: testing spit. They&#8217;ve discovered that conditions such as breast [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-search-for-biomarkers-of-disease-in-spit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/the-search-for-biomarkers-of-disease-in-spit/</feedburner:origLink></item>
		<item>
		<title>Jaw Necrosis Common after Radiation for Oral Cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/Qt-nEzvjoIc/</link>
		<comments>http://oralcancernews.org/wp/jaw-necrosis-common-after-radiation-for-oral-cancer/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 23:33:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[Multidisciplinary Head and Neck Cancer Symposium]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[osteradionecrosis]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[University of Texas MD And]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12395</guid>
		<description><![CDATA[Source: MedpageToday.com Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco. &#160; &#160; Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. Explain that osteoradionecrosis of the jaw [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/jaw-necrosis-common-after-radiation-for-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/jaw-necrosis-common-after-radiation-for-oral-cancer/</feedburner:origLink></item>
		<item>
		<title>Squamous cell subgroups respond differently to treatment</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/Gdz5VxBNLEw/</link>
		<comments>http://oralcancernews.org/wp/squamous-cell-subgroups-respond-differently-to-treatment/#comments</comments>
		<pubDate>Sat, 28 Jan 2012 15:33:41 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[extracapsular spread]]></category>
		<category><![CDATA[lymph nodes]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[resection margins]]></category>
		<category><![CDATA[survival rates]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12388</guid>
		<description><![CDATA[Source: www.medscape.com Author: Nancy A. Melville A long-term follow-up of patients with head and neck squamous cell carcinoma suggests that only certain high-risk subgroups benefit from radiation plus chemotherapy. This information will spare patients who will not benefit from undergoing the additional treatment. According to the study, presented here at the 2012 Multidisciplinary Head and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/squamous-cell-subgroups-respond-differently-to-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/squamous-cell-subgroups-respond-differently-to-treatment/</feedburner:origLink></item>
		<item>
		<title>Erlotinib dose doubled for smokers with head/neck cancer</title>
		<link>http://feedproxy.google.com/~r/oralcancernews/KsIl/~3/BYYoxn6qa4I/</link>
		<comments>http://oralcancernews.org/wp/erlotinib-dose-doubled-for-smokers-with-headneck-cancer/#comments</comments>
		<pubDate>Sat, 28 Jan 2012 15:25:19 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[EGFR]]></category>
		<category><![CDATA[epidermal growth factor receptor]]></category>
		<category><![CDATA[erlotinib]]></category>
		<category><![CDATA[inhibitor]]></category>
		<category><![CDATA[skin rash]]></category>
		<category><![CDATA[smokers]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[Tarceva]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12384</guid>
		<description><![CDATA[Source: www.oncologyreport.com Author: Miriam E. Tucker Giving smokers a higher, short-course dose of erlotinib before definitive surgery for squamous cell carcinoma of the head and neck resulted in favorable responses for the first patients evaluated in a small pilot study. Investigators gave 300 mg of erlotinib (Tarceva) to smokers daily and 150 mg daily to [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/erlotinib-dose-doubled-for-smokers-with-headneck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://oralcancernews.org/wp/erlotinib-dose-doubled-for-smokers-with-headneck-cancer/</feedburner:origLink></item>
	</channel>
</rss>

